← Leaderboards
Maryam Yousefi
Stanford University
$168,832
Attributed
$168,832
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $64.3K · FY2019–21$100K$75K$50K$25K$0
'19
'20
'21
Funding mix
By agency
NIH$168,832 · 1
By mechanism
F32$168,832 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Donna M Peehl$4,923,077
- Joseph C Wu$80,370,369
- Daniel L Rubin$10,989,812
- Todd W Ridky$5,236,268
- Heike Elizabeth Daldrup-Link$23,256,656
Others in their field
Other Emerging Leaders on “Crispr/Cas Technology”
- William H. Peranteau · Children'S Hosp Of Philadelphia$16,284,236
- Crystal Mackall · Children'S Hosp Of Philadelphia$13,090,386
- Jacqueline K White · Jackson Laboratory$11,881,166
- Jesse M Engreitz · Stanford University$8,776,071
- Peng Jiang · Rutgers, The State Univ Of N.J.$6,578,144
- Yin Shen · University Of California, San Francisco$6,515,212
Research focus
Crispr/Cas TechnologyAllelesAcuteCre-LoxpBiochemicalBiologicalCancer BiologyAftercareBaseCancer GenomeCancer TherapyCarboplatinCell PhysiologyCessation Of LifeClinicClinical ResearchCancer CellClinical Trials DesignCancer EtiologyCohortCombinatorialCostCost EffectiveDesign
Grant awards (3)
Therapeutic dissection of genotype-specific lung cancer vulnerabilities$43,296
F32 · FY2021 · CA · contact PI
Therapeutic dissection of genotype-specific lung cancer vulnerabilities$64,310
F32 · FY2020 · CA · contact PI
Therapeutic dissection of genotype-specific lung cancer vulnerabilities$61,226
F32 · FY2019 · CA · contact PI